Trial Profile

A Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104).

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Narlaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin; Ritonavir
Indications Hepatitis C
Focus Therapeutic Use
Acronyms NEXT-1
Sponsors Merck Sharp & Dohme

Most Recent Events

26 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
02 Nov 2009 Interim results presented at the American Association for the Study of Liver Diseases (AASLD) 2009 Annual Meeting, according to a Schering-Plough media release.
30 Oct 2009 Interim results were presented at AASID 2009.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com